CRISPR Therapeutics AG (CRSP) Forms $47.27 Double Top; La-z-boy (LZB) Shorts Raised By 5.47%

La-Z-Boy Incorporated (NYSE:LZB) Logo

CRISPR Therapeutics AG (CRSP) formed double top with $49.16 target or 4.00% above today’s $47.27 share price. CRISPR Therapeutics AG (CRSP) has $2.23B valuation. The stock decreased 4.70% or $2.33 during the last trading session, reaching $47.27. About 1.26 million shares traded or 6.29% up from the average. CRISPR Therapeutics AG (NASDAQ:CRSP) has risen 144.93% since April 25, 2017 and is uptrending. It has outperformed by 133.38% the S&P500.

La-z-boy Incorporated (NYSE:LZB) had an increase of 5.47% in short interest. LZB’s SI was 1.84 million shares in April as released by FINRA. Its up 5.47% from 1.75M shares previously. With 437,600 avg volume, 4 days are for La-z-boy Incorporated (NYSE:LZB)’s short sellers to cover LZB’s short positions. The SI to La-z-boy Incorporated’s float is 3.97%. The stock decreased 0.34% or $0.1 during the last trading session, reaching $29.3. About 224,628 shares traded. La-Z-Boy Incorporated (NYSE:LZB) has risen 8.12% since April 25, 2017 and is uptrending. It has underperformed by 3.43% the S&P500.

Analysts await CRISPR Therapeutics AG (NASDAQ:CRSP) to report earnings on May, 10. They expect $-0.67 EPS, down 24.07% or $0.13 from last year’s $-0.54 per share.

Among 5 analysts covering CRISPR Therapeutics (NASDAQ:CRSP), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. CRISPR Therapeutics has $30 highest and $22 lowest target. $25.17’s average target is -46.75% below currents $47.27 stock price. CRISPR Therapeutics had 5 analyst reports since November 14, 2016 according to SRatingsIntel. The stock of CRISPR Therapeutics AG (NASDAQ:CRSP) has “Overweight” rating given on Monday, November 14 by Piper Jaffray. Guggenheim initiated it with “Buy” rating and $30 target in Monday, November 14 report. The stock of CRISPR Therapeutics AG (NASDAQ:CRSP) earned “Overweight” rating by Barclays Capital on Monday, November 14. The firm earned “Neutral” rating on Tuesday, November 15 by Citigroup.

Since February 22, 2018, it had 0 insider buys, and 1 insider sale for $2.09 million activity. On Thursday, February 22 RICCIO LOUIS M JR sold $2.09M worth of La-Z-Boy Incorporated (NYSE:LZB) or 65,910 shares.

La-Z-Boy Incorporated manufactures, markets, imports, exports, distributes, and retails upholstery furniture products, accessories, and casegoods furniture products in the United States, Canada, and internationally. The company has market cap of $1.38 billion. It operates through Upholstery, Casegoods, and Retail divisions. It has a 19.1 P/E ratio. The Upholstery segment makes and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, ottomans, and sleeper sofas.

La-Z-Boy Incorporated (NYSE:LZB) Institutional Positions Chart